This ann puts in writing that we can be almost certain when it comes to safety. No safety concerns in independent review, no one has left the trial so far without completing it.
While this is a good ann, it's a bit of a place holder in that it tells us something we were pretty sure of anyway. It may well be that the two big anns that we're waiting for are running late. These are:
What's happening with Perseis
The concussion trial starting.
If it's the case that these are late, it's not surprising. If there is any deal to be made with Perseis, well, these things can take longer than you'd like and better to get the best deal than work to an artificial timetable. The concussion trial involves government so there can be all sorts of things that slow you down there.
I would also like to see updates on the TBI and FXS trials. It would be good to see the TBI trial numbers really accelerating the way they're supposed to and, while I suspect the FXS trial is ticking along, it would be good to hear that enrolment and completion are on target.
NEU Price at posting:
8.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)